Literature DB >> 24147467

Esophagography after pneumomediastinum without CT findings of esophageal perforation: is it necessary?

Cheng-Hsien Wu1, Chien-Ming Chen, Chien-Cheng Chen, Yon-Cheong Wong, Chao-Jan Wang, Wan-Chak Lo, Li-Jen Wang.   

Abstract

OBJECTIVE: The purpose of our study was to determine the necessity of fluoroscopic esophagography in patients with pneumomediastinum on CT but without CT findings of esophageal perforation.
MATERIALS AND METHODS: From January 1, 2006, through December 31, 2010, there were 4305 fluoroscopic esophagography examinations including 533 with CT identified from a search of our PACS. Patients with pneumomediastinum on CT who were subsequently referred for emergent fluoroscopic esophagography to exclude esophageal perforation were enrolled. Fluoroscopic esophagography examinations performed within 3 days of CT were included. Patients with a history of esophageal disease were excluded. As a result, 103 patients were enrolled in the study; patients were divided into groups on the basis of whether there was additional clinical history of esophageal damage (trauma group) or not (nontrauma group). Images were reviewed by two board-certified radiologists blinded to the clinical data and radiologic reports for the presence or absence of esophageal perforation. A positive result on CT was defined as esophageal injury or periesophageal infiltration that coexisted with periesophageal air. A positive fluoroscopic esophagography result was defined as oral contrast medium leakage from the esophagus.
RESULTS: Esophageal perforation was diagnosed in 15 of the 103 patients. The CT findings were significantly correlated with esophageal perforation (p < 0.001 in the trauma group, and p = 0.001 in the nontrauma group). The respective sensitivity and negative predictive value (NPV) of CT versus fluoroscopic esophagography in the trauma group were 100% versus 66.7% and 100% versus 87.9%; in the nontrauma group, the sensitivity and NPV were 100% for CT and fluoroscopic esophagography. Thus, the sensitivity and NPV of CT were either superior or equal to those of fluoroscopic esophagography.
CONCLUSION: The results of our study suggest that performing fluoroscopic esophagography in patients with pneumomediastinum is unnecessary when CT is negative for esophageal perforation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24147467     DOI: 10.2214/AJR.12.10345

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  6 in total

Review 1.  Scary gas: a spectrum of soft tissue gas encountered in the axial body (part II).

Authors:  Claire K Sandstrom; Sherif F Osman; Ken F Linnau
Journal:  Emerg Radiol       Date:  2017-03-02

2.  Mediastinal fluid as a predictor for esophageal perforation as the cause of pneumomediastinum.

Authors:  Cletus Fuhrmann; Matthew Weissenborn; Sehar Salman
Journal:  Emerg Radiol       Date:  2020-08-19

Review 3.  Characterizing and quantifying low-value diagnostic imaging internationally: a scoping review.

Authors:  Elin Kjelle; Eivind Richter Andersen; Arne Magnus Krokeide; Lesley J J Soril; Leti van Bodegom-Vos; Fiona M Clement; Bjørn Morten Hofmann
Journal:  BMC Med Imaging       Date:  2022-04-21       Impact factor: 2.795

4.  UK guidelines on oesophageal dilatation in clinical practice.

Authors:  Sarmed S Sami; Hasan N Haboubi; Yeng Ang; Philip Boger; Pradeep Bhandari; John de Caestecker; Helen Griffiths; Rehan Haidry; Hans-Ulrich Laasch; Praful Patel; Stuart Paterson; Krish Ragunath; Peter Watson; Peter D Siersema; Stephen E Attwood
Journal:  Gut       Date:  2018-02-24       Impact factor: 23.059

5.  A dental nightmare, resolved: what a radiologist needs to know when consulted about ingestion of dental foreign body material.

Authors:  Mark Guelfguat; Jason Dipoce; James Dipoce
Journal:  BJR Case Rep       Date:  2016-05-05

6.  Boerhaave Syndrome Causing Bilateral Empyemas.

Authors:  Divya Chalikonda; Joseph Yoo; Drew Johnson; Christina Tofani
Journal:  ACG Case Rep J       Date:  2019-09-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.